The latest in RSV protection for kids: An antibody treatment called Beyfortus


RSV is the leading cause of hospitalization in infants and one of the main drivers of child mortality

Nirsevimab can protect babies throughout the duration of a virus season

Nirsevimab is not a vaccine. It’s a preventive drug that offers passive immunity.

Prevention is essential because RSV-specific treatments don’t exist

RSV season is around the corner, so parents should check with their child’s pediatrician about nirsevimab.

Source: Read Full Article